Straits Times Index
3,176.51 -11.15 (-0.35%) Nikkei
37,068.35 -1,011.35 (-2.66%) Hang Seng
16,224.14 -161.73 (-0.99%) FTSE 100
7,895.85 +18.80 (+0.24%) Bitcoin USD
63,953.13 +2,071.96 (+3.35%) CMC Crypto 200
1,371.97 +59.34 (+4.52%)
Medicine Man Technologies, Inc. (SHWZ)
| Previous close | 0.7000 |
| Open | 0.7100 |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's range | 0.6715 - 0.7475 |
| 52-week range | 0.4800 - 1.5500 |
| Volume | |
| Avg. volume | 71,571 |
| Market cap | 52.716M |
| Beta (5Y monthly) | 1.48 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.6600 |
| Earnings date | 08 May 2024 - 13 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 2.83 |
Insider MonkeyMedicine Man Technologies, Inc. (PNK:SHWZ) Q4 2023 Earnings Call Transcript
Medicine Man Technologies, Inc. (PNK:SHWZ) Q4 2023 Earnings Call Transcript March 27, 2024 Medicine Man Technologies, Inc. misses on earnings expectations. Reported EPS is $-0.43 EPS, expectations were $-0.13. Medicine Man Technologies, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). […]
CNW GroupSchwazze Announces Fourth Quarter and Full Year 2023 Financial Results
Medicine Man Technologies, Inc., operating as Schwazze, (OTCQX: SHWZ) (Cboe: SHWZ) ("Schwazze" or the "Company"), today announced financial and operational results for the fourth quarter and full year ended December 31, 2023.
PR NewswireSchwazze Sets Fourth Quarter and Full Year 2023 Conference Call for March 27, 2024 at 5:00 p.m. ET
Medicine Man Technologies, Inc., operating as Schwazze, (OTCQX: SHWZ) (Cboe: SHWZ) ("Schwazze" or the "Company"), will host a conference call on Wednesday, March 27, 2024 at 5:00 p.m. Eastern time to discuss its financial and operational results for the fourth quarter and full year ended December 31, 2023. The Company's results will be reported in a press release prior to the call.
